Related to this topic: Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Peutz-Jeghers Syndrome

Synonyms: Polyposis, Hamartomatous Intestinal polyps-and-spots syndrome

Peutz-Jeghers syndrome is an autosomal dominant disorder characterised by mucosal pigmentation of the lips and gums with multiple intestinal hamartomatous polyps and an increased risk of various cancers compared to the general population.
The syndrome is co-named after Peutz who first recognised the association of gastrointestinal polyposis and mucocutaneous pigmentation in 1921 and Jeghers who wrote the definitive descriptive reports and drew more wide-spread attention to the condition in 1949.

Epidemiology

Prevalence - rare, around 1/50 000 1.

Genetics

Autosomal dominant condition with high penetrance. In up to two thirds of cases, mutations can be identified in the serine/threonine kinase gene STK11(LKB1)2. STK11 is thought to be a tumour suppressor gene.

Presentation
  • Family history - asymptomatic but requesting investigation/counselling.
  • Deeply pigmented lesions on the lips (cross the vermillion border) and buccal mucosa. May also be present on hands and feet (particularly palms and soles) and around anus and genitalia. These lesions may be most prominent in infancy and fade after puberty.
  • Repeated bouts of abdominal pain in a young patient (due to obstruction or intussusception)
  • Unexplained intestinal bleeding in a young patient or iron-deficiency anaemia.
  • Rectal prolapse
  • Precocious puberty
  • Nasal, bronchial, biliary tract, uterine or bladder polyps

Peutz-Jeghers Syndrome belongs to group of single gene disorders that carry a greatly increased risk of colorectal and other cancers.
Hamartomatous Polyposis Syndromes3 include:

  • Juvenile polyposis syndrome - multiple hamartomatous polyps of the colon and rectum, usually manifesting during childhood.
  • Cowden Syndrome - multiple hamartomas usually presenting as mucocutaneous lesions; also associated with neurodevelopmental abnormalities and gastrointestinal polyposis.
  • Lhermitte-Duclos syndrome - very rare, slow-growing unilateral cerebellar mass of hamartomatous origin.

Previously, phenotypic features were the only way to identify a particular disease which was difficult when the different syndromes overlapped. Now, it is possible to categorise more accurately using molecular analysis and to give individuals a better assessment of their potential cancer risk and need for surveillance.

Other non-hamartomatous autosomal dominant disorders that increase risk of colorectal cancers are:

  • Familial adenomatous polypolis - characterised by large numbers of adenomas (>100) of the colon and rectum. The development of large bowel cancer is virtually certain without prophylactic surgery.
  • Hereditary non-polyposis colorectal cancer - result of mutation in a DNA mismatch repair gene. Disorder is defined empirically by family history (3 or more family members affected by colorectal cancer or more than 2 with colorectal cancer and one with endometrial cancer in 2 or more generations where one affected relative is under 50 at diagnosis and at least one must be a first degree relative) or by demonstration of a gene mutation.
Investigations:
  • FBC
  • Imaging - OGD, small bowel follow-through or capsular endoscopy4, colonoscopy to determine presence and location of intestinal polyps.
  • Genetic analysis
Management

If Peutz-Jeghers is suspected on the basis of clinical criteria, the patient should be referred to a regional genetics centre for formal counselling and mutation analysis of the relevant gene1.
Surgical excision of lesions may be required - endoscopic polypectomy for diagnosis and control of symptoms; laparotomy and resection reserved for repeated intussusception or persistent intestinal bleeding5.

Complications:
  • High cancer risk. Most common cancers are gastroesophageal, small bowel, colorectal and pancreatic. Also risk of ductal breast cancer, thyroid, lung, uterine, sertoli cell testicular tumours or ovarian sex cord tumors. The cancer-susceptibility is thought to arise from mutation activating serine/threonine kinase.
  • GI bleeding
  • intussusception
  • Rectal prolapse
  • Adhesions and obstructions from repeated surgeries
Prognosis6

Cumulative risks for developing cancer:

  • by 20 years - 2%
  • by 30 years - 5%
  • by 40 years - 17%
  • by 50 years - 31%
  • by 60 years - 60%
  • by 70 years - 85%

Cumulative risk of developing GI cancers (gastroesophageal, small bowel, colorectal and pancreatic) :

  • by 30 years - 1%
  • by 40 years - 9%
  • by 50 years - 15%
  • by 60 years - 33%

Cumulative risk of breast cancer in women with Peutz-Jeghers syndrome:

  • by 40 years - 8%
  • by 60 years - 31%

Prevention

Benefits of surveillance are uncertain but cancer risk is high so current recommendations (British Society of Gastroenterology)1 are:

  • Colonoscopy or flexible sigmoidoscopy from age 18 years at 3 yearly intervals.
  • OGD from age 25 years at 3 yearly intervals.

Members of the family of an affected family where a causative gene has been identified should be referred for gene counselling and predictive gene testing. Where they test negative, there is no indication for their continued surveillance1.


Document References
  1. Dunlop MG; Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome.; Gut. 2002 Oct;51 Suppl 5:V21-7.
  2. OMIM - Peutz-Jeghers syndrome.
  3. Carethers JM; Unwinding the heterogeneous nature of hamartomatous polyposis syndromes.; JAMA. 2005 Nov 16;294(19):2498-500.
  4. Schulmann K, Hollerbach S, Kraus K, et al; Feasibility and diagnostic utility of video capsule endoscopy for the detection of small bowel polyps in patients with hereditary polyposis syndromes.; Am J Gastroenterol. 2005 Jan;100(1):27-37. [abstract]
  5. Lin BC, Lien JM, Chen RJ, et al; Combined endoscopic and surgical treatment for the polyposis of Peutz-Jeghers syndrome.; Surg Endosc. 2000 Dec;14(12):1185-7. [abstract]
  6. Hearle N, Schumacher V, Menko FH, et al; Frequency and spectrum of cancers in the Peutz-Jeghers syndrome.; Clin Cancer Res. 2006 May 15;12(10):3209-15. [abstract]
Acknowledgements EMIS is grateful to Dr Chloe Borton for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 1100
Document Version: 21
DocRef: bgp1275
Last Updated: 20 Jun 2007
Review Date: 19 Jun 2009
Patient UK Current Health News










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site



PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page